|
|
||||||||
1From the Departments of Clinical Science, Section of Ophthalmology and 2Integrative Medical Biology, Section of Anatomy, University of Umeå, Umeå, Sweden; the 3Centre of Musculoskeletal Research, University of Gävle, Gävle, Sweden; and the 4Copenhagen Muscle Research Center, Department of Molecular Muscle Biology, Rigshospitalet, Copenhagen, Denmark.
PURPOSE. To investigate the myosin heavy chain (MyHC) composition of human extraocular (EOM) and levator palpebrae (LP) muscle fibers.
METHODS. Adult human EOMs and LP were studied with SDS-PAGE, immunoblots, and immunocytochemistry, with antibodies against six MyHC isoforms. Myofibrillar adenosine triphosphatase (mATPase) and reduced nicotinamide adenine dinucleotide (NADH)-TR activity and fiber area were also determined.
RESULTS. Most of the fibers in both layers stained strongly with anti-MyHCIIa. Approximately 14% of the fibers in the global layer and 16% in the orbital layer were labeled with anti-MyHCI. The remaining 24% of the fibers in the global layer and 3% in the orbital layer were not stained with either of these two antibodies, but were reactive to anti-MyHCeom (MyHCeompos/MyHCIIaneg fibers). The fibers stained with anti-MyHCI had acid-stable mATPase activity, and the remainder of the fibers had alkaline-stable mATPase activity. Almost all the slow fibers stained with both anti-MyHCI and anti-MyHCslow tonic in both layers. Anti-MyHC
-cardiac stained approximately 26% of these slow fibers in the orbital layer and 7% in the global layer. Some slow fibers in both layers lacked staining with anti-MyHCslow tonic or with anti-MyHC
-cardiac. MyHCemb and/or MyHCeom were also present in some of the fibers of all the groups. The LP did not stain with anti-MyHCslow tonic.
CONCLUSIONS. The present study revealed that the human EOMs have a very complex fiber type and MyHC composition and differ significantly from the EOMs of other species. The features of the LP were distinct from those of the four recti, the obliquus superior, and the limb muscles.
This article has been cited by other articles:
![]() |
D. Kjellgren, P. Stal, L. Larsson, D. Furst, and F. Pedrosa-Domellof Uncoordinated expression of Myosin heavy chains and Myosin-binding protein C isoforms in human extraocular muscles. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4188 - 4193. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Fischer, M. T. Budak, M. Bakay, J. R. Gorospe, D. Kjellgren, F. Pedrosa-Domellof, E. P. Hoffman, and T. S. Khurana Definition of the unique human extraocular muscle allotype by expression profiling Physiol Genomics, August 11, 2005; 22(3): 283 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lossos, L. Baala, D. Soffer, L. Averbuch-Heller, S. Dotan, A. Munnich, S. Lyonnet, J. M. Gomori, A. Genem, M. Neufeld, et al. A novel autosomal recessive myopathy with external ophthalmoplegia linked to chromosome 17p13.1-p12 Brain, January 1, 2005; 128(1): 42 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kjellgren, L.-E. Thornell, I. Virtanen, and F. Pedrosa-Domellof Laminin Isoforms in Human Extraocular Muscles Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4233 - 4239. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khanna, G. Cheng, B. Gong, M. J. Mustari, and J. D. Porter Genome-Wide Transcriptional Profiles Are Consistent with Functional Specialization of the Extraocular Muscle Layers Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 3055 - 3066. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Vistisen, K. Roepstorff, C. Roepstorff, A. Bonen, B. van Deurs, and B. Kiens Sarcolemmal FAT/CD36 in human skeletal muscle colocalizes with caveolin-3 and is more abundant in type 1 than in type 2 fibers J. Lipid Res., April 1, 2004; 45(4): 603 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kjellgren, M. Ryan, K. Ohlendieck, L.-E. Thornell, and F. Pedrosa-Domellof Sarco(endo)plasmic Reticulum Ca2+ ATPases (SERCA1 and -2) in Human Extraocular Muscles Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5057 - 5062. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |